Paul Goepfert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul goepfert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Goepfert Today - Breaking & Trending Today

Are new COVID boosters the answer to Alabama's mini-surge in hospitalizations?

Are new COVID boosters the answer to Alabama's mini-surge in hospitalizations?
al.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from al.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Alabama At Birmingham , Donald Williamson , Paul Goepfert , Alabama Vaccine Research Clinic , Alabama Hospital Association , Advisory Committee On Immunization Practices , Centers For Disease , Advisory Committee , Immunization Practices , Disease Control ,

Health - 1540 WADK Newport

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday.

During a meeting, the agency s Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK.

Short of a full recommendation, the committee said adults aged 60 and over may get the vaccines based on individual needs and after consultation with a doctor.

The vaccines have already received approval from the U.S. Food and Drug Administration, so the final step is for CDC director Dr. Rochelle Walensky to sign off on the recommendations, which she is expected to do.

Here s what the panel s vote could mean for older Americans:

Why is RSV so dangerous for older adults?

RSV can affect people of all ages, though some age groups ar ....

United States , Jason Schwartz , Paul Goepfert , Dan Barouch , Rochelle Walensky , Shira Doron , Nathan Posner Anadolu Agency , Tuft Medical Center , Centers For Disease , University Of Alabama At Birmingham Hospital , Harvard Medical School , Yale School Of Public Health , Drug Administration , Advisory Committee On Immunization Practices , Anadolu Agency , Disease Control , Advisory Committee , Immunization Practices , Birmingham Hospital , Vaccine Research , Beth Israel Deaconess Medical Center , Yale School , Public Health , Gregory Poland , Mayo Clinic , Radio Station ,

Health - KSYL-AM

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday.

During a meeting, the agency s Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK.

Short of a full recommendation, the committee said adults aged 60 and over may get the vaccines based on individual needs and after consultation with a doctor.

The vaccines have already received approval from the U.S. Food and Drug Administration, so the final step is for CDC director Dr. Rochelle Walensky to sign off on the recommendations, which she is expected to do.

Here s what the panel s vote could mean for older Americans:

Why is RSV so dangerous for older adults?

RSV can affect people of all ages, though some age groups ar ....

United States , Shira Doron , Rochelle Walensky , Paul Goepfert , Jason Schwartz , Dan Barouch , Nathan Posner Anadolu Agency , Drug Administration , Tuft Medical Center , University Of Alabama At Birmingham Hospital , Advisory Committee On Immunization Practices , Yale School Of Public Health , Harvard Medical School , Centers For Disease , Anadolu Agency , Disease Control , Advisory Committee , Immunization Practices , Birmingham Hospital , Vaccine Research , Beth Israel Deaconess Medical Center , Yale School , Public Health , Gregory Poland , Mayo Clinic , Syl 970 ,

Health News - Media One Radio Group (WWSE | WJTN | WHUG | WKSN | WQFX

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday.

During a meeting, the agency s Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK.

Short of a full recommendation, the committee said adults aged 60 and over may get the vaccines based on individual needs and after consultation with a doctor.

The vaccines have already received approval from the U.S. Food and Drug Administration, so the final step is for CDC director Dr. Rochelle Walensky to sign off on the recommendations, which she is expected to do.

Here s what the panel s vote could mean for older Americans:

Why is RSV so dangerous for older adults?

RSV can affect people of all ages, though some age groups ar ....

United States , Paul Goepfert , Rochelle Walensky , Dan Barouch , Shira Doron , Jason Schwartz , Centers For Disease , Nathan Posner Anadolu Agency , Drug Administration , Tuft Medical Center , Harvard Medical School , Yale School Of Public Health , University Of Alabama At Birmingham Hospital , Advisory Committee On Immunization Practices , Anadolu Agency , Disease Control , Advisory Committee , Immunization Practices , Birmingham Hospital , Vaccine Research , Beth Israel Deaconess Medical Center , Yale School , Public Health , Gregory Poland , Mayo Clinic , Media One Radio Group ,